Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$87.35
-2.6%
$73.27
$30.90
$100.00
$28.18B3.649.30 million shs9.26 million shs
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
$134.83
$134.83
$116.44
$177.88
N/AN/A391,243 shsN/A
Moderna, Inc. stock logo
MRNA
Moderna
$25.14
+3.5%
$28.84
$23.15
$79.96
$9.78B1.939.06 million shs13.01 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affirm Holdings, Inc. stock logo
AFRM
Affirm
0.00%-1.25%+10.63%+48.25%+117.13%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00%0.00%0.00%0.00%+13,482,999,900.00%
Moderna, Inc. stock logo
MRNA
Moderna
0.00%+4.36%-5.52%-8.45%-65.32%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$87.35
-2.6%
$73.27
$30.90
$100.00
$28.18B3.649.30 million shs9.26 million shs
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
$134.83
$134.83
$116.44
$177.88
N/AN/A391,243 shsN/A
Moderna, Inc. stock logo
MRNA
Moderna
$25.14
+3.5%
$28.84
$23.15
$79.96
$9.78B1.939.06 million shs13.01 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affirm Holdings, Inc. stock logo
AFRM
Affirm
0.00%-1.25%+10.63%+48.25%+117.13%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00%0.00%0.00%0.00%+13,482,999,900.00%
Moderna, Inc. stock logo
MRNA
Moderna
0.00%+4.36%-5.52%-8.45%-65.32%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.67
Moderate Buy$79.04-9.51% Downside
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
0.00
N/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
2.04
Hold$42.8870.57% Upside

Current Analyst Ratings Breakdown

Latest ARCH, MRNA, and AFRM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$70.00 ➝ $108.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$75.00 ➝ $97.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$90.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$56.00 ➝ $85.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$91.00 ➝ $94.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Outperform$75.00 ➝ $105.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$67.00 ➝ $100.00
8/29/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$90.00 ➝ $94.00
8/26/2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$82.00 ➝ $95.00
8/22/2025
Moderna, Inc. stock logo
MRNA
Moderna
Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetUnderperform$18.00 ➝ $15.00
(Data available from 9/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$3.24B8.69$0.24 per share364.95$9.51 per share9.19
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
$3.06B3.20N/AN/A$28.33 per share0.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$52.19M$0.13671.97140.895.691.62%1.80%0.49%11/6/2025 (Estimated)
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/A0.00N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
-$3.56B-$7.53N/AN/AN/A-94.31%-25.96%-20.09%11/6/2025 (Estimated)

Latest ARCH, MRNA, and AFRM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/28/2025Q4 2025
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$0.11$0.20+$0.09$0.20$834.94 million$876.42 million
8/1/2025Q2 2025
Moderna, Inc. stock logo
MRNA
Moderna
-$2.99-$2.13+$0.86-$2.13$116.26 million$142.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Affirm Holdings, Inc. stock logo
AFRM
Affirm
N/AN/AN/AN/AN/A
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.55
11.54
11.54
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/A
3.93
3.77

Institutional Ownership

CompanyInstitutional Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
69.29%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/A
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
11.82%
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/A
Moderna, Inc. stock logo
MRNA
Moderna
11.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2,206322.60 million284.47 millionOptionable
Arch Biopartners Inc. stock logo
ARCH
Arch Biopartners
N/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
5,800389.08 million346.28 millionOptionable

Recent News About These Companies

Comerica Bank Purchases 29,020 Shares of Moderna, Inc. $MRNA
Is Moderna Stock Underperforming the S&P 500?
Insider Buyers At Moderna Likely Disappointed With 11% Slide

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Affirm stock logo

Affirm NASDAQ:AFRM

$87.35 -2.31 (-2.58%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$87.22 -0.13 (-0.14%)
As of 09/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months. The company has active merchants covering small businesses, large enterprises, direct-to-consumer brands, brick-and-mortar stores, and companies with an omni-channel presence. Its merchants represent a range of industries, including sporting goods and outdoors, furniture and homewares, travel and ticketing, apparel, accessories, consumer electronics, and jewelry. Affirm Holdings, Inc. was founded in 2012 and is headquartered in San Francisco, California.

Arch Biopartners stock logo

Arch Biopartners NYSE:ARCH

$134.83 0.00 (0.00%)
As of 01/14/2025

Moderna stock logo

Moderna NASDAQ:MRNA

$25.14 +0.86 (+3.54%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$25.02 -0.12 (-0.49%)
As of 09/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.